Dry Cupping Therapy in Knee Osteoarthritis
VentosaOA
The Effects of Dry Cupping on Pain, Function and Quality of Life of Women With Knee Osteoarthritis: Protocol for a Placebo-controlled Randomized Trial
1 other identifier
interventional
62
1 country
1
Brief Summary
Introduction: Knee osteoarthritis (KOA) is the biggest cause of pain and disability worldwide. As a non-pharmacological approach, ventosatherapia has been used to control pain, improve function and quality of life. However, there is a lack of high-quality scientific evidence regarding its effects on this condition. Objective: To evaluate the effects of dry cupping on pain, function and quality of life in women with KOA. Methods: This is a randomized, blinded placebo-controlled protocol. 62 women diagnosed with KOA will be recruited, based on the clinical criteria of the American College of Rheumatology, who will be randomly divided into two groups (31 per group): dry cupping and dry cupping sham.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2020
CompletedFirst Posted
Study publicly available on registry
April 2, 2020
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2023
CompletedJune 17, 2025
June 1, 2025
7 months
March 29, 2020
June 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Numerical Rating Scale (NRS)
Subjective measure in which individuals rate their pain on an eleven-point numerical scale. Such scale will be positioned in front of the participant and will vary from 0 to 10 points, with 0 being the complete absence of pain and 10 being the worst pain imaginable by the individual
baseline, 3 ,6 and 10 weeks after.
Secondary Outcomes (8)
Change from Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
baseline, 3 ,6 and 10 weeks after.
Change from 30-second Chair Stand Test
baseline, 6 and 10 weeks after.
Change from 8-step Stair Climb Test
baseline, 6 and 10 weeks after.
Change from 40m Fast Paced Walk Test
baseline, 6 and 10 weeks after.
Change from Short-Form 36 quality of life
baseline, 6 and 10 weeks after.
- +3 more secondary outcomes
Study Arms (2)
Dry cupping group
EXPERIMENTALThe dry cupping will be applied with a force of two suctions generating a negative pressure on the skin during the time of 15 minutes.
Dry cupping sham group
PLACEBO COMPARATORThe dry cupping sham group will receive the same procedures as the dry cup group, with the difference that the negative pressure imposed after application will be released in a few seconds.
Interventions
Dry cupping therapy application on the patient's skin
Eligibility Criteria
You may qualify if:
- Diagnosed with KOA based on ACR clinical criteria;
- Knee pain intensity between 3 and 8, according to the Numerical Pain Scale (END);
- BMI less than 35 kg / m2.
You may not qualify if:
- Having undergone physical therapy treatment for the knee in the 3 months prior to the project;
- Be engaged in\> 45 minutes / week in accumulated physical activity of at least moderate intensity;
- To have been submitted to the application and / or intervention with the wind therapy previously.
- Have used corticosteroid infiltration in the knee in the last 6 months;
- Present any medical restrictions that make it impossible for them to participate in the proposed assessments and interventions (cardiorespiratory, neurological and / or musculoskeletal changes);
- Presenting a diagnosis of fibromyalgia, rheumatoid arthritis or some systemic inflammatory arthritis;
- Presenting a ligament or meniscal injury diagnosed clinically or with a positive result in the Apley tests or anterior / posterior drawer;
- Have had previous surgery on the ankle, knee or hip;
- Present a clinical diagnosis of some dementia or inability to answer the questionnaires related to the study;
- Present any contraindications for the use of ventosatherapia (skin lesion in the region where it will be applied, cancer, kidney failure, liver and heart failure, pacemaker, pregnancy);
- Having uncontrolled diabetes and hypertension;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marcelo Cardoso de Souza
Santa Cruz, Rio Grande do Norte, 59200-000, Brazil
Related Publications (4)
Silva HJA, Saragiotto BT, Silva RS, Lins CAA, de Souza MC. Dry cupping in the treatment of individuals with non-specific chronic low back pain: a protocol for a placebo-controlled, randomised, double-blind study. BMJ Open. 2019 Dec 22;9(12):e032416. doi: 10.1136/bmjopen-2019-032416.
PMID: 31871257BACKGROUNDPeat G, Thomas E, Duncan R, Wood L, Hay E, Croft P. Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care. Ann Rheum Dis. 2006 Oct;65(10):1363-7. doi: 10.1136/ard.2006.051482. Epub 2006 Apr 20.
PMID: 16627539BACKGROUNDCavalcanti RR, Almeida Silva HJ, Pontes-Silva A, Avila MA, de Souza CG, Sousa CO, Scattone Silva R, Barbosa GM, de Souza MC. Dry cupping therapy has no effect on pain, function, or quality of life in women with knee osteoarthritis: Randomized placebo-controlled trial. Braz J Phys Ther. 2026 Jan-Feb;30(1):101259. doi: 10.1016/j.bjpt.2025.101259. Epub 2025 Oct 2.
PMID: 41043303DERIVEDPontes NS, Barbosa GM, Almeida Silva HJ, Scattone Silva R, Souza CG, Lins CAA, de Souza MC. Effects of dry cupping on pain, function and quality of life in women with knee osteoarthritis: a protocol for a sham-controlled randomised trial. BMJ Open. 2020 Dec 24;10(12):e039857. doi: 10.1136/bmjopen-2020-039857.
PMID: 33361075DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marcelo C de Souza, PT, PhD
Universidade Federal do Rio Grande do Norte
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- To avoid any type of selection bias, the confidential allocation method will be through opaque envelopes, sealed and numbered consecutively. The randomization process will be carried out by an independent researcher who will not be involved in other study procedures. The group in which the participant will be allocated will be revealed to the researcher responsible for the consultations prior to the first intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct Professor
Study Record Dates
First Submitted
March 29, 2020
First Posted
April 2, 2020
Study Start
February 1, 2023
Primary Completion
September 1, 2023
Study Completion
December 2, 2023
Last Updated
June 17, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
there is not a plan to make individual participant data (IPD) available to other researchers